Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hdx
|
ENSMUSG00000034551.6 | highly divergent homeobox |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chrX_111696219_111697388 | Hdx | 276 | 0.946398 | 0.48 | 1.0e-04 | Click! |
chrX_111748459_111748610 | Hdx | 51455 | 0.146762 | 0.03 | 8.4e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr12_29529828_29531185 | 9.92 |
Gm20208 |
predicted gene, 20208 |
609 |
0.74 |
chr8_12947702_12949640 | 7.67 |
Mcf2l |
mcf.2 transforming sequence-like |
718 |
0.37 |
chr15_39392623_39392878 | 7.52 |
Rims2 |
regulating synaptic membrane exocytosis 2 |
950 |
0.68 |
chr16_77596529_77597235 | 7.13 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
1980 |
0.16 |
chr6_134886811_134888239 | 7.13 |
Gpr19 |
G protein-coupled receptor 19 |
243 |
0.87 |
chr15_85673548_85673944 | 6.94 |
Lncppara |
long noncoding RNA near Ppara |
20130 |
0.13 |
chr11_85995030_85996078 | 6.80 |
Gm11443 |
predicted gene 11443 |
45059 |
0.15 |
chr5_150261018_150262108 | 6.51 |
Fry |
FRY microtubule binding protein |
1796 |
0.34 |
chr13_69736281_69736725 | 6.38 |
Ube2ql1 |
ubiquitin-conjugating enzyme E2Q family-like 1 |
3386 |
0.16 |
chr13_48264468_48265300 | 6.27 |
A330033J07Rik |
RIKEN cDNA A330033J07 gene |
2261 |
0.19 |
chr1_189341351_189342108 | 6.08 |
Kcnk2 |
potassium channel, subfamily K, member 2 |
1626 |
0.32 |
chr8_109250884_109251908 | 6.01 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
1530 |
0.52 |
chr7_128689234_128689975 | 5.99 |
Gm43580 |
predicted gene 43580 |
1069 |
0.26 |
chr16_81202167_81203211 | 5.98 |
Ncam2 |
neural cell adhesion molecule 2 |
1932 |
0.44 |
chr7_78884387_78884983 | 5.95 |
Mir7-2 |
microRNA 7-2 |
3592 |
0.14 |
chr18_64890376_64890890 | 5.90 |
Nedd4l |
neural precursor cell expressed, developmentally down-regulated gene 4-like |
140 |
0.95 |
chr16_77500388_77501627 | 5.65 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
623 |
0.62 |
chr19_44757990_44758435 | 5.58 |
Pax2 |
paired box 2 |
818 |
0.54 |
chr4_82496866_82497618 | 5.54 |
Nfib |
nuclear factor I/B |
2074 |
0.34 |
chr9_112232067_112232798 | 5.54 |
Arpp21 |
cyclic AMP-regulated phosphoprotein, 21 |
69 |
0.97 |
chr2_52557337_52558561 | 5.53 |
Cacnb4 |
calcium channel, voltage-dependent, beta 4 subunit |
611 |
0.74 |
chr6_80020534_80021026 | 5.44 |
Lrrtm4 |
leucine rich repeat transmembrane neuronal 4 |
1137 |
0.48 |
chr13_58809397_58810364 | 5.39 |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
1189 |
0.34 |
chrX_152643367_152644550 | 5.34 |
Shroom2 |
shroom family member 2 |
34 |
0.98 |
chr1_143643975_143644626 | 5.29 |
Cdc73 |
cell division cycle 73, Paf1/RNA polymerase II complex component |
1775 |
0.33 |
chr3_119498694_119499278 | 5.23 |
Gm23432 |
predicted gene, 23432 |
139888 |
0.05 |
chr12_31710202_31710828 | 5.18 |
Gpr22 |
G protein-coupled receptor 22 |
3411 |
0.2 |
chr10_81229656_81230911 | 5.17 |
Atcay |
ataxia, cerebellar, Cayman type |
502 |
0.53 |
chr12_100779025_100779814 | 5.10 |
Dglucy |
D-glutamate cyclase |
283 |
0.88 |
chr1_143640264_143641520 | 5.10 |
B3galt2 |
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 |
228 |
0.59 |
chr6_92478725_92480195 | 5.07 |
Prickle2 |
prickle planar cell polarity protein 2 |
1932 |
0.44 |
chr7_60047037_60047188 | 5.05 |
Snrpn |
small nuclear ribonucleoprotein N |
42001 |
0.06 |
chrX_23284413_23285126 | 5.03 |
Klhl13 |
kelch-like 13 |
60 |
0.99 |
chr3_87566316_87566693 | 5.01 |
ETV3L |
ets variant 3-like |
15255 |
0.14 |
chr17_90452047_90452824 | 4.98 |
Nrxn1 |
neurexin I |
2387 |
0.31 |
chr16_75092043_75093126 | 4.90 |
Gm49676 |
predicted gene, 49676 |
54649 |
0.14 |
chr13_109442519_109443753 | 4.87 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
953 |
0.73 |
chrX_165326738_165328112 | 4.86 |
Glra2 |
glycine receptor, alpha 2 subunit |
32 |
0.99 |
chr12_36039703_36040241 | 4.83 |
Tspan13 |
tetraspanin 13 |
37 |
0.98 |
chr13_83527676_83528436 | 4.83 |
Mef2c |
myocyte enhancer factor 2C |
2082 |
0.45 |
chr14_66344363_66345813 | 4.77 |
Stmn4 |
stathmin-like 4 |
707 |
0.65 |
chr9_112228690_112229153 | 4.77 |
2310075C17Rik |
RIKEN cDNA 2310075C17 gene |
1342 |
0.41 |
chr3_146768414_146769205 | 4.74 |
Prkacb |
protein kinase, cAMP dependent, catalytic, beta |
1452 |
0.4 |
chr2_6881042_6881689 | 4.73 |
Gm13389 |
predicted gene 13389 |
2905 |
0.24 |
chr3_79144294_79146166 | 4.73 |
Rapgef2 |
Rap guanine nucleotide exchange factor (GEF) 2 |
253 |
0.94 |
chr5_131532921_131534054 | 4.66 |
Auts2 |
autism susceptibility candidate 2 |
910 |
0.58 |
chr5_17848825_17849185 | 4.66 |
Cd36 |
CD36 molecule |
724 |
0.8 |
chr1_115686481_115687365 | 4.66 |
Cntnap5a |
contactin associated protein-like 5A |
2167 |
0.34 |
chr6_115312557_115313010 | 4.66 |
Pparg |
peroxisome proliferator activated receptor gamma |
48168 |
0.12 |
chr10_102159422_102159718 | 4.62 |
Mgat4c |
MGAT4 family, member C |
491 |
0.89 |
chr13_83717521_83718816 | 4.60 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
3213 |
0.17 |
chr16_97168581_97168970 | 4.59 |
Dscam |
DS cell adhesion molecule |
1977 |
0.47 |
chr1_25827305_25827886 | 4.52 |
Adgrb3 |
adhesion G protein-coupled receptor B3 |
835 |
0.43 |
chr5_43236846_43237650 | 4.46 |
Cpeb2 |
cytoplasmic polyadenylation element binding protein 2 |
67 |
0.96 |
chr8_54956010_54956394 | 4.45 |
Gpm6a |
glycoprotein m6a |
1359 |
0.38 |
chr8_108536302_108537095 | 4.43 |
Gm39244 |
predicted gene, 39244 |
249 |
0.95 |
chr12_29537800_29538885 | 4.42 |
Myt1l |
myelin transcription factor 1-like |
3120 |
0.28 |
chr12_31714190_31714356 | 4.34 |
Gpr22 |
G protein-coupled receptor 22 |
326 |
0.87 |
chr16_77416103_77416788 | 4.34 |
Gm38071 |
predicted gene, 38071 |
179 |
0.91 |
chr4_102420955_102421939 | 4.33 |
Pde4b |
phosphodiesterase 4B, cAMP specific |
71 |
0.99 |
chr3_88214322_88216234 | 4.33 |
Mir3093 |
microRNA 3093 |
107 |
0.63 |
chr7_99383478_99385192 | 4.32 |
Gdpd5 |
glycerophosphodiester phosphodiesterase domain containing 5 |
1563 |
0.33 |
chr6_54564534_54565307 | 4.30 |
Scrn1 |
secernin 1 |
1569 |
0.36 |
chr19_8838893_8839483 | 4.27 |
Gng3 |
guanine nucleotide binding protein (G protein), gamma 3 |
6 |
0.61 |
chr3_127407787_127409013 | 4.25 |
Ank2 |
ankyrin 2, brain |
554 |
0.71 |
chr14_124675118_124677112 | 4.25 |
Fgf14 |
fibroblast growth factor 14 |
1012 |
0.63 |
chr1_25828771_25829000 | 4.24 |
Adgrb3 |
adhesion G protein-coupled receptor B3 |
626 |
0.54 |
chr16_77502982_77503216 | 4.23 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
2715 |
0.18 |
chrX_7919510_7921219 | 4.20 |
Pcsk1n |
proprotein convertase subtilisin/kexin type 1 inhibitor |
542 |
0.52 |
chr1_42703141_42704653 | 4.19 |
Pantr2 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 2 |
4155 |
0.16 |
chr1_88698916_88699320 | 4.16 |
Arl4c |
ADP-ribosylation factor-like 4C |
2758 |
0.23 |
chr15_76519928_76521866 | 4.15 |
Scrt1 |
scratch family zinc finger 1 |
1005 |
0.28 |
chr12_119235620_119236481 | 4.14 |
Itgb8 |
integrin beta 8 |
2720 |
0.31 |
chrX_88112223_88112880 | 4.13 |
Il1rapl1 |
interleukin 1 receptor accessory protein-like 1 |
3094 |
0.35 |
chr10_49787984_49789251 | 4.13 |
Grik2 |
glutamate receptor, ionotropic, kainate 2 (beta 2) |
137 |
0.6 |
chr8_40186709_40187062 | 4.12 |
Fgf20 |
fibroblast growth factor 20 |
100068 |
0.07 |
chr12_75310638_75311218 | 4.12 |
Rhoj |
ras homolog family member J |
2047 |
0.44 |
chr11_32000314_32000822 | 4.11 |
Nsg2 |
neuron specific gene family member 2 |
66 |
0.98 |
chr6_55617797_55618517 | 4.08 |
Neurod6 |
neurogenic differentiation 6 |
63106 |
0.11 |
chr3_28265481_28265639 | 4.06 |
Tnik |
TRAF2 and NCK interacting kinase |
1917 |
0.36 |
chr18_35214570_35215443 | 4.02 |
Lrrtm2 |
leucine rich repeat transmembrane neuronal 2 |
2 |
0.52 |
chr13_46421073_46421328 | 4.00 |
Rbm24 |
RNA binding motif protein 24 |
622 |
0.78 |
chr7_143738564_143739329 | 4.00 |
Osbpl5 |
oxysterol binding protein-like 5 |
1353 |
0.31 |
chr11_108341800_108342206 | 3.98 |
Apoh |
apolipoprotein H |
1351 |
0.35 |
chr6_77247866_77248159 | 3.93 |
Lrrtm1 |
leucine rich repeat transmembrane neuronal 1 |
5090 |
0.29 |
chr12_29536509_29537451 | 3.90 |
Myt1l |
myelin transcription factor 1-like |
1758 |
0.36 |
chr15_85676712_85677176 | 3.89 |
Lncppara |
long noncoding RNA near Ppara |
23328 |
0.12 |
chr15_48791303_48792616 | 3.83 |
Csmd3 |
CUB and Sushi multiple domains 3 |
26 |
0.99 |
chr9_110051810_110053856 | 3.82 |
Map4 |
microtubule-associated protein 4 |
781 |
0.54 |
chr4_68953001_68953567 | 3.82 |
Brinp1 |
bone morphogenic protein/retinoic acid inducible neural specific 1 |
1113 |
0.68 |
chr13_84064321_84064873 | 3.81 |
Gm17750 |
predicted gene, 17750 |
175 |
0.96 |
chr12_41483283_41485192 | 3.81 |
Lrrn3 |
leucine rich repeat protein 3, neuronal |
2194 |
0.36 |
chr4_102257323_102258061 | 3.81 |
Pde4b |
phosphodiesterase 4B, cAMP specific |
2462 |
0.42 |
chr12_29528407_29529244 | 3.79 |
Myt1l |
myelin transcription factor 1-like |
424 |
0.85 |
chr1_69790500_69791180 | 3.77 |
Gm37930 |
predicted gene, 37930 |
19972 |
0.21 |
chr14_76419153_76419898 | 3.75 |
Tsc22d1 |
TSC22 domain family, member 1 |
697 |
0.78 |
chr12_70344161_70344678 | 3.74 |
Trim9 |
tripartite motif-containing 9 |
2670 |
0.25 |
chr8_128363458_128363919 | 3.73 |
Nrp1 |
neuropilin 1 |
4291 |
0.25 |
chr12_92303420_92303633 | 3.71 |
Gm6841 |
predicted gene 6841 |
84149 |
0.1 |
chr3_127224567_127225242 | 3.71 |
Ank2 |
ankyrin 2, brain |
943 |
0.48 |
chr18_54820794_54821363 | 3.67 |
Gm33732 |
predicted gene, 33732 |
2711 |
0.26 |
chr12_31711839_31712627 | 3.66 |
Gpr22 |
G protein-coupled receptor 22 |
1693 |
0.32 |
chr14_123626367_123627548 | 3.66 |
Nalcn |
sodium leak channel, non-selective |
4 |
0.98 |
chr14_108913558_108914298 | 3.64 |
Slitrk1 |
SLIT and NTRK-like family, member 1 |
230 |
0.97 |
chr18_69521278_69522871 | 3.64 |
Tcf4 |
transcription factor 4 |
73 |
0.98 |
chr12_3368833_3369546 | 3.64 |
Gm48511 |
predicted gene, 48511 |
760 |
0.54 |
chr1_81077232_81078427 | 3.62 |
Nyap2 |
neuronal tyrosine-phophorylated phosphoinositide 3-kinase adaptor 2 |
246 |
0.96 |
chr4_46989593_46989744 | 3.59 |
Gabbr2 |
gamma-aminobutyric acid (GABA) B receptor, 2 |
2205 |
0.28 |
chr6_136169672_136170219 | 3.57 |
Grin2b |
glutamate receptor, ionotropic, NMDA2B (epsilon 2) |
1944 |
0.34 |
chr2_6869935_6870654 | 3.57 |
Celf2 |
CUGBP, Elav-like family member 2 |
1678 |
0.39 |
chr12_71049290_71050137 | 3.56 |
Arid4a |
AT rich interactive domain 4A (RBP1-like) |
1372 |
0.4 |
chr8_34890130_34891317 | 3.56 |
Tnks |
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase |
572 |
0.8 |
chr11_87759834_87761999 | 3.54 |
Tspoap1 |
TSPO associated protein 1 |
329 |
0.75 |
chr2_83814030_83814462 | 3.53 |
Fam171b |
family with sequence similarity 171, member B |
1610 |
0.34 |
chr4_36952312_36953412 | 3.51 |
Gm12371 |
predicted gene 12371 |
104 |
0.95 |
chr8_61226832_61226983 | 3.51 |
Sh3rf1 |
SH3 domain containing ring finger 1 |
2663 |
0.29 |
chr2_34368049_34368262 | 3.51 |
Pbx3 |
pre B cell leukemia homeobox 3 |
2691 |
0.28 |
chr14_39469812_39470401 | 3.50 |
Nrg3 |
neuregulin 3 |
2560 |
0.44 |
chr18_62924974_62925324 | 3.49 |
Apcdd1 |
adenomatosis polyposis coli down-regulated 1 |
2643 |
0.26 |
chr4_82496503_82496855 | 3.49 |
Nfib |
nuclear factor I/B |
2637 |
0.29 |
chr13_56895826_56896120 | 3.47 |
Trpc7 |
transient receptor potential cation channel, subfamily C, member 7 |
20 |
0.98 |
chr6_28828230_28829085 | 3.47 |
Lrrc4 |
leucine rich repeat containing 4 |
1688 |
0.37 |
chr2_63182035_63182719 | 3.46 |
Kcnh7 |
potassium voltage-gated channel, subfamily H (eag-related), member 7 |
1793 |
0.52 |
chr3_146769678_146770812 | 3.46 |
Prkacb |
protein kinase, cAMP dependent, catalytic, beta |
16 |
0.98 |
chr2_134787470_134787766 | 3.45 |
Plcb1 |
phospholipase C, beta 1 |
1088 |
0.52 |
chr4_46202294_46203178 | 3.45 |
Xpa |
xeroderma pigmentosum, complementation group A |
6425 |
0.17 |
chr5_111425949_111427685 | 3.43 |
Gm43119 |
predicted gene 43119 |
3228 |
0.22 |
chr2_4017802_4019015 | 3.39 |
Frmd4a |
FERM domain containing 4A |
664 |
0.68 |
chrX_88114828_88115362 | 3.39 |
Il1rapl1 |
interleukin 1 receptor accessory protein-like 1 |
550 |
0.84 |
chr2_178327060_178328225 | 3.39 |
Phactr3 |
phosphatase and actin regulator 3 |
86 |
0.98 |
chr1_184997307_184998530 | 3.38 |
Mark1 |
MAP/microtubule affinity regulating kinase 1 |
1557 |
0.41 |
chr7_73543070_73543221 | 3.38 |
Chd2 |
chromodomain helicase DNA binding protein 2 |
1315 |
0.29 |
chr3_115710711_115712215 | 3.37 |
S1pr1 |
sphingosine-1-phosphate receptor 1 |
3609 |
0.24 |
chr8_33747278_33748028 | 3.36 |
Smim18 |
small integral membrane protein 18 |
117 |
0.95 |
chr13_67728554_67729691 | 3.35 |
Zfp65 |
zinc finger protein 65 |
51 |
0.6 |
chr17_80946268_80946852 | 3.35 |
Tmem178 |
transmembrane protein 178 |
1928 |
0.35 |
chr13_105444000_105445296 | 3.34 |
Htr1a |
5-hydroxytryptamine (serotonin) receptor 1A |
1009 |
0.69 |
chr10_69705909_69707430 | 3.34 |
Ank3 |
ankyrin 3, epithelial |
191 |
0.97 |
chr7_19175632_19177533 | 3.33 |
Eml2 |
echinoderm microtubule associated protein like 2 |
161 |
0.88 |
chr15_68931111_68931412 | 3.33 |
Khdrbs3 |
KH domain containing, RNA binding, signal transduction associated 3 |
1193 |
0.53 |
chr13_109443973_109444887 | 3.33 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
2247 |
0.46 |
chrX_166344665_166345995 | 3.33 |
Gpm6b |
glycoprotein m6b |
488 |
0.85 |
chr10_92160735_92161461 | 3.33 |
Rmst |
rhabdomyosarcoma 2 associated transcript (non-coding RNA) |
1663 |
0.4 |
chr2_70564530_70567543 | 3.32 |
Gad1 |
glutamate decarboxylase 1 |
341 |
0.83 |
chr3_13946382_13947629 | 3.31 |
Ralyl |
RALY RNA binding protein-like |
594 |
0.84 |
chr16_69469508_69470143 | 3.31 |
4930428D20Rik |
RIKEN cDNA 4930428D20 gene |
330556 |
0.01 |
chr15_78118661_78118936 | 3.30 |
A730060N03Rik |
RIKEN cDNA A730060N03 gene |
908 |
0.42 |
chr14_75962509_75963193 | 3.29 |
Kctd4 |
potassium channel tetramerisation domain containing 4 |
7842 |
0.18 |
chr7_133608635_133609002 | 3.27 |
Gm45671 |
predicted gene 45671 |
592 |
0.63 |
chr1_42229552_42230263 | 3.27 |
Gm9915 |
predicted gene 9915 |
180 |
0.95 |
chr9_113792658_113793898 | 3.26 |
Clasp2 |
CLIP associating protein 2 |
48 |
0.98 |
chr5_81023833_81024680 | 3.26 |
Adgrl3 |
adhesion G protein-coupled receptor L3 |
2446 |
0.43 |
chr18_35213919_35214231 | 3.24 |
Ctnna1 |
catenin (cadherin associated protein), alpha 1 |
855 |
0.42 |
chr15_25415436_25415919 | 3.23 |
Gm48957 |
predicted gene, 48957 |
614 |
0.58 |
chr3_148976888_148978178 | 3.21 |
Gm43573 |
predicted gene 43573 |
11619 |
0.18 |
chr1_42711455_42712692 | 3.20 |
Pantr2 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 2 |
1381 |
0.34 |
chr4_140244024_140245271 | 3.19 |
Igsf21 |
immunoglobulin superfamily, member 21 |
2137 |
0.36 |
chrX_41589814_41589965 | 3.19 |
Gria3 |
glutamate receptor, ionotropic, AMPA3 (alpha 3) |
20308 |
0.23 |
chr9_122570014_122570846 | 3.19 |
9530059O14Rik |
RIKEN cDNA 9530059O14 gene |
2069 |
0.26 |
chr12_89815493_89816199 | 3.17 |
Nrxn3 |
neurexin III |
3363 |
0.39 |
chr15_77151796_77152203 | 3.17 |
Rbfox2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
1557 |
0.32 |
chr18_33460259_33461386 | 3.16 |
Nrep |
neuronal regeneration related protein |
2613 |
0.29 |
chr1_9601164_9602408 | 3.16 |
Vxn |
vexin |
587 |
0.67 |
chr4_110285249_110285423 | 3.16 |
Elavl4 |
ELAV like RNA binding protein 4 |
1280 |
0.61 |
chr16_67617739_67618070 | 3.16 |
Cadm2 |
cell adhesion molecule 2 |
2589 |
0.35 |
chr3_118430167_118430853 | 3.14 |
Gm26871 |
predicted gene, 26871 |
186 |
0.92 |
chr18_31446492_31447667 | 3.13 |
Syt4 |
synaptotagmin IV |
327 |
0.87 |
chr11_35544219_35545325 | 3.12 |
Slit3 |
slit guidance ligand 3 |
87 |
0.98 |
chr4_110284889_110285145 | 3.12 |
Elavl4 |
ELAV like RNA binding protein 4 |
1599 |
0.53 |
chr11_104233637_104234521 | 3.12 |
Mapt |
microtubule-associated protein tau |
2495 |
0.22 |
chr6_110647799_110648648 | 3.11 |
Gm20387 |
predicted gene 20387 |
2307 |
0.32 |
chr19_47017205_47017356 | 3.10 |
Nt5c2 |
5'-nucleotidase, cytosolic II |
2127 |
0.2 |
chr1_23764777_23765091 | 3.09 |
B3gat2 |
beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S) |
2923 |
0.36 |
chr2_158606690_158608449 | 3.09 |
Gm14204 |
predicted gene 14204 |
3021 |
0.15 |
chr4_15883184_15883580 | 3.09 |
Calb1 |
calbindin 1 |
2075 |
0.27 |
chr12_46815602_46816139 | 3.08 |
Nova1 |
NOVA alternative splicing regulator 1 |
1090 |
0.54 |
chr16_77503379_77503945 | 3.07 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
3278 |
0.16 |
chr9_79875436_79876355 | 3.07 |
Gm3211 |
predicted gene 3211 |
37305 |
0.12 |
chr18_69597107_69597709 | 3.06 |
Tcf4 |
transcription factor 4 |
2128 |
0.42 |
chr15_53342031_53342311 | 3.06 |
Ext1 |
exostosin glycosyltransferase 1 |
3488 |
0.33 |
chr15_25026077_25026585 | 3.06 |
Gm2824 |
predicted gene 2824 |
1006 |
0.65 |
chr2_84648361_84648948 | 3.05 |
Ctnnd1 |
catenin (cadherin associated protein), delta 1 |
117 |
0.92 |
chr3_84219260_84219630 | 3.05 |
Trim2 |
tripartite motif-containing 2 |
1400 |
0.49 |
chr13_46420548_46420948 | 3.05 |
Rbm24 |
RNA binding motif protein 24 |
197 |
0.96 |
chr6_60687288_60687444 | 3.05 |
Mageb16-ps2 |
melanoma antigen family B, 16, pseudogene 2 |
83693 |
0.08 |
chr17_91086370_91086959 | 3.04 |
Gm47307 |
predicted gene, 47307 |
1742 |
0.26 |
chr14_118422287_118423239 | 3.04 |
Gm5672 |
predicted gene 5672 |
46569 |
0.11 |
chr17_10314038_10315183 | 3.04 |
Qk |
quaking |
4751 |
0.26 |
chr7_46399318_46399469 | 3.02 |
Kcnc1 |
potassium voltage gated channel, Shaw-related subfamily, member 1 |
1745 |
0.31 |
chr15_77244882_77245075 | 3.01 |
Rbfox2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
528 |
0.72 |
chr12_86681553_86682494 | 3.01 |
Vash1 |
vasohibin 1 |
3323 |
0.18 |
chr8_67815077_67815228 | 3.01 |
Psd3 |
pleckstrin and Sec7 domain containing 3 |
3081 |
0.37 |
chrX_60146958_60147936 | 3.00 |
Mcf2 |
mcf.2 transforming sequence |
196 |
0.96 |
chr18_37147091_37147753 | 3.00 |
Pcdhac2 |
protocadherin alpha subfamily C, 2 |
3919 |
0.14 |
chr1_81079064_81079824 | 2.99 |
Nyap2 |
neuronal tyrosine-phophorylated phosphoinositide 3-kinase adaptor 2 |
1861 |
0.49 |
chr10_18470218_18471289 | 2.99 |
Nhsl1 |
NHS-like 1 |
772 |
0.72 |
chr14_86299488_86299717 | 2.99 |
Gm32815 |
predicted gene, 32815 |
132 |
0.94 |
chr7_51623529_51624502 | 2.99 |
Slc17a6 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 |
1133 |
0.51 |
chr6_86029811_86029962 | 2.98 |
Add2 |
adducin 2 (beta) |
1139 |
0.34 |
chr14_93885189_93885472 | 2.98 |
Pcdh9 |
protocadherin 9 |
418 |
0.9 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 12.6 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
3.7 | 11.0 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
2.8 | 8.3 | GO:0072069 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
2.7 | 11.0 | GO:0060486 | Clara cell differentiation(GO:0060486) |
2.3 | 16.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
2.2 | 6.7 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
2.2 | 6.6 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
2.0 | 6.1 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
2.0 | 6.1 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
1.8 | 10.8 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
1.8 | 5.3 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
1.7 | 5.2 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
1.7 | 5.1 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
1.7 | 18.8 | GO:0097090 | presynaptic membrane organization(GO:0097090) |
1.7 | 5.1 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
1.7 | 5.1 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
1.7 | 18.4 | GO:0071625 | vocalization behavior(GO:0071625) |
1.6 | 3.3 | GO:0046684 | response to pyrethroid(GO:0046684) |
1.6 | 4.9 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
1.6 | 6.3 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
1.5 | 1.5 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
1.5 | 4.6 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
1.5 | 6.0 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
1.5 | 11.9 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
1.5 | 3.0 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
1.5 | 4.4 | GO:0033058 | directional locomotion(GO:0033058) |
1.4 | 8.6 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
1.4 | 4.3 | GO:1902669 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
1.4 | 4.3 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
1.4 | 4.2 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
1.4 | 4.2 | GO:0035910 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
1.4 | 11.0 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
1.4 | 9.5 | GO:0016198 | axon choice point recognition(GO:0016198) |
1.3 | 3.9 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
1.3 | 5.2 | GO:0030091 | protein repair(GO:0030091) |
1.3 | 2.6 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
1.3 | 2.5 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
1.3 | 6.3 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
1.1 | 1.1 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
1.1 | 1.1 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
1.1 | 1.1 | GO:0061743 | motor learning(GO:0061743) |
1.1 | 2.2 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
1.1 | 7.6 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
1.1 | 5.3 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
1.1 | 5.3 | GO:1990000 | amyloid fibril formation(GO:1990000) |
1.0 | 2.1 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
1.0 | 2.1 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
1.0 | 9.2 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.0 | 2.0 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
1.0 | 1.9 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
1.0 | 6.7 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.9 | 3.8 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.9 | 57.4 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.9 | 3.7 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.9 | 1.9 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) |
0.9 | 1.8 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.9 | 1.8 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.9 | 3.6 | GO:0090427 | activation of meiosis(GO:0090427) |
0.9 | 3.5 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.9 | 3.5 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.9 | 1.7 | GO:0006808 | regulation of nitrogen utilization(GO:0006808) |
0.9 | 0.9 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.8 | 7.6 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.8 | 6.7 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.8 | 1.7 | GO:0030035 | microspike assembly(GO:0030035) |
0.8 | 1.7 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.8 | 1.6 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.8 | 3.3 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.8 | 1.6 | GO:1904395 | positive regulation of postsynaptic membrane organization(GO:1901628) regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) positive regulation of neuromuscular junction development(GO:1904398) |
0.8 | 0.8 | GO:2000851 | positive regulation of glucocorticoid secretion(GO:2000851) |
0.8 | 0.8 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.8 | 2.4 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.8 | 5.5 | GO:0097264 | self proteolysis(GO:0097264) |
0.8 | 8.4 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.8 | 3.0 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.8 | 1.5 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.8 | 1.5 | GO:0046959 | habituation(GO:0046959) |
0.7 | 3.0 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.7 | 3.7 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.7 | 3.0 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.7 | 0.7 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
0.7 | 3.6 | GO:0060174 | limb bud formation(GO:0060174) |
0.7 | 4.3 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.7 | 15.2 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.7 | 2.2 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.7 | 1.4 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.7 | 2.1 | GO:0097503 | sialylation(GO:0097503) |
0.7 | 2.1 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.7 | 2.1 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.7 | 2.1 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.7 | 2.8 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.7 | 20.2 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.7 | 1.4 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
0.7 | 3.4 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.7 | 7.5 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.7 | 1.4 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.7 | 5.4 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.7 | 2.0 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.7 | 2.0 | GO:0007525 | somatic muscle development(GO:0007525) |
0.7 | 4.0 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.7 | 5.3 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.7 | 7.2 | GO:0001964 | startle response(GO:0001964) |
0.6 | 1.9 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.6 | 1.3 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.6 | 1.3 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.6 | 2.5 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.6 | 1.2 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.6 | 1.2 | GO:0060166 | olfactory pit development(GO:0060166) |
0.6 | 3.7 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.6 | 1.2 | GO:0021604 | cranial nerve structural organization(GO:0021604) |
0.6 | 10.2 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.6 | 0.6 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.6 | 1.2 | GO:0036166 | phenotypic switching(GO:0036166) |
0.6 | 1.2 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
0.6 | 5.8 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.6 | 1.2 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
0.6 | 5.7 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.6 | 1.1 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.6 | 3.4 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
0.6 | 1.1 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
0.6 | 1.7 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.6 | 2.2 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.6 | 2.2 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.6 | 2.8 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.6 | 3.9 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.5 | 2.2 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.5 | 4.9 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.5 | 1.6 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
0.5 | 1.6 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.5 | 2.2 | GO:0042891 | antibiotic transport(GO:0042891) |
0.5 | 2.2 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.5 | 0.5 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.5 | 10.8 | GO:0007616 | long-term memory(GO:0007616) |
0.5 | 1.6 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.5 | 4.2 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.5 | 2.6 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
0.5 | 2.1 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.5 | 1.5 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.5 | 1.0 | GO:0060686 | regulation of prostatic bud formation(GO:0060685) negative regulation of prostatic bud formation(GO:0060686) |
0.5 | 1.5 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
0.5 | 2.0 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.5 | 1.0 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.5 | 7.5 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.5 | 1.0 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.5 | 2.0 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.5 | 1.5 | GO:0060437 | lung growth(GO:0060437) |
0.5 | 1.5 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.5 | 1.5 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.5 | 2.0 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.5 | 1.9 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.5 | 0.5 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.5 | 1.5 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.5 | 3.8 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.5 | 1.4 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.5 | 1.4 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.5 | 0.5 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.5 | 3.3 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.5 | 0.9 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.5 | 3.3 | GO:0008038 | neuron recognition(GO:0008038) |
0.5 | 0.9 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.5 | 2.3 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.5 | 6.4 | GO:0006828 | manganese ion transport(GO:0006828) |
0.5 | 0.9 | GO:0071504 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.4 | 0.9 | GO:0007625 | grooming behavior(GO:0007625) |
0.4 | 4.5 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.4 | 4.5 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.4 | 0.9 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.4 | 1.8 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.4 | 1.3 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.4 | 2.2 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.4 | 3.0 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.4 | 0.9 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.4 | 2.5 | GO:0031115 | negative regulation of microtubule polymerization or depolymerization(GO:0031111) negative regulation of microtubule polymerization(GO:0031115) |
0.4 | 0.8 | GO:0034331 | cell junction maintenance(GO:0034331) |
0.4 | 0.4 | GO:0030800 | negative regulation of cyclic nucleotide metabolic process(GO:0030800) |
0.4 | 2.1 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.4 | 0.4 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
0.4 | 1.6 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.4 | 2.4 | GO:0030432 | peristalsis(GO:0030432) |
0.4 | 1.2 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
0.4 | 1.2 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.4 | 1.6 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.4 | 0.4 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.4 | 0.8 | GO:0061055 | myotome development(GO:0061055) |
0.4 | 1.2 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.4 | 3.5 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.4 | 1.2 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.4 | 3.0 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.4 | 0.4 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.4 | 1.1 | GO:0032811 | negative regulation of epinephrine secretion(GO:0032811) |
0.4 | 1.5 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.4 | 0.7 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.4 | 1.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.4 | 1.8 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
0.4 | 0.7 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.4 | 2.6 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.4 | 1.8 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.4 | 0.4 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.4 | 0.4 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.4 | 0.7 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.4 | 1.1 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.4 | 3.6 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.4 | 0.4 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.4 | 0.7 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.4 | 1.4 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.4 | 1.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.4 | 2.9 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.4 | 0.7 | GO:1901017 | negative regulation of potassium ion transmembrane transporter activity(GO:1901017) |
0.4 | 1.1 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.4 | 25.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.4 | 1.8 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.4 | 6.0 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.4 | 3.5 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.3 | 1.4 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.3 | 0.7 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.3 | 0.3 | GO:0001997 | positive regulation of the force of heart contraction by epinephrine-norepinephrine(GO:0001997) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.3 | 0.7 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.3 | 3.1 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.3 | 1.7 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.3 | 2.0 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.3 | 0.7 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.3 | 1.0 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.3 | 3.0 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.3 | 2.0 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.3 | 1.0 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
0.3 | 0.3 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) |
0.3 | 0.6 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.3 | 3.9 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.3 | 0.6 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.3 | 0.6 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.3 | 0.9 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.3 | 1.5 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.3 | 0.6 | GO:0014075 | response to amine(GO:0014075) |
0.3 | 0.3 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) |
0.3 | 0.9 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.3 | 0.6 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.3 | 7.0 | GO:0019228 | neuronal action potential(GO:0019228) |
0.3 | 0.3 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.3 | 2.1 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.3 | 0.6 | GO:0033227 | dsRNA transport(GO:0033227) |
0.3 | 0.9 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.3 | 0.3 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.3 | 0.6 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.3 | 0.3 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.3 | 1.8 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.3 | 0.6 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.3 | 3.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.3 | 2.0 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.3 | 1.1 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.3 | 0.3 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.3 | 0.8 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.3 | 1.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.3 | 1.4 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.3 | 2.5 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.3 | 0.8 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.3 | 0.8 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.3 | 1.7 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.3 | 1.1 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) |
0.3 | 2.5 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.3 | 0.8 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.3 | 2.5 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.3 | 1.6 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.3 | 0.3 | GO:0072174 | metanephric tubule formation(GO:0072174) |
0.3 | 0.8 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.3 | 2.2 | GO:0097369 | sodium ion import(GO:0097369) |
0.3 | 0.3 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.3 | 0.5 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.3 | 1.6 | GO:0003093 | regulation of glomerular filtration(GO:0003093) |
0.3 | 1.6 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.3 | 0.5 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.3 | 0.8 | GO:0032960 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) |
0.3 | 0.5 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.3 | 0.5 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.3 | 19.3 | GO:0007612 | learning(GO:0007612) |
0.3 | 0.8 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.3 | 0.5 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.3 | 0.3 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.3 | 0.3 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
0.3 | 0.3 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.3 | 0.8 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.3 | 0.8 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.3 | 1.3 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.3 | 0.3 | GO:0048382 | mesendoderm development(GO:0048382) |
0.3 | 0.3 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.3 | 0.8 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.3 | 0.5 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.2 | 0.2 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.2 | 0.5 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.2 | 1.5 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.2 | 0.5 | GO:0014894 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to stimulus involved in regulation of muscle adaptation(GO:0014874) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.2 | 0.7 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.2 | 0.7 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.2 | 2.2 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.2 | 1.0 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 0.2 | GO:0022009 | central nervous system vasculogenesis(GO:0022009) |
0.2 | 1.9 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.2 | 0.7 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.2 | 0.5 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.2 | 0.5 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.2 | 5.3 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 0.5 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
0.2 | 0.2 | GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) |
0.2 | 6.9 | GO:0034605 | cellular response to heat(GO:0034605) |
0.2 | 1.2 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.2 | 3.1 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.2 | 0.7 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.2 | 17.8 | GO:0007411 | axon guidance(GO:0007411) |
0.2 | 1.7 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.2 | 0.7 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.2 | 0.5 | GO:0022030 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.2 | 0.7 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.2 | 0.5 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.2 | 2.5 | GO:1990403 | embryonic brain development(GO:1990403) |
0.2 | 1.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 0.7 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.2 | 1.3 | GO:0072010 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.2 | 0.9 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.2 | 0.7 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.2 | 1.3 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 2.2 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
0.2 | 0.4 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.2 | 1.8 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.2 | 0.9 | GO:0019532 | oxalate transport(GO:0019532) |
0.2 | 0.4 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.2 | 2.0 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.2 | 0.4 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.2 | 0.4 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.2 | 0.9 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.2 | 1.1 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.2 | 0.4 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.2 | 0.2 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.2 | 2.7 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.2 | 0.4 | GO:0014028 | notochord formation(GO:0014028) |
0.2 | 0.2 | GO:0003140 | determination of left/right asymmetry in lateral mesoderm(GO:0003140) nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
0.2 | 0.2 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.2 | 0.6 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.2 | 0.4 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.2 | 0.4 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.2 | 0.4 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.2 | 1.2 | GO:0060539 | diaphragm development(GO:0060539) |
0.2 | 0.2 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.2 | 1.0 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.2 | 1.0 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.2 | 0.2 | GO:0048242 | epinephrine secretion(GO:0048242) |
0.2 | 0.6 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.2 | 0.8 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.2 | 0.4 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
0.2 | 0.2 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.2 | 0.4 | GO:0014732 | skeletal muscle atrophy(GO:0014732) striated muscle atrophy(GO:0014891) |
0.2 | 2.6 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.2 | 0.2 | GO:0072197 | ureter morphogenesis(GO:0072197) |
0.2 | 1.0 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.2 | 0.2 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.2 | 0.6 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.2 | 0.2 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.2 | 0.2 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.2 | 0.2 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
0.2 | 0.4 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.2 | 0.4 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) |
0.2 | 1.9 | GO:1901186 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.2 | 0.6 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.2 | 1.5 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 0.8 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.2 | 0.6 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.2 | 0.4 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.2 | 0.4 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.2 | 0.7 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
0.2 | 0.2 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.2 | 0.2 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.2 | 0.2 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.2 | 1.8 | GO:0060074 | synapse maturation(GO:0060074) |
0.2 | 3.2 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.2 | 0.7 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.2 | 0.2 | GO:0043622 | cortical microtubule organization(GO:0043622) |
0.2 | 0.2 | GO:0061590 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.2 | 0.7 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.2 | 1.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 8.3 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.2 | 0.3 | GO:0050955 | thermoception(GO:0050955) |
0.2 | 0.2 | GO:0071455 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.2 | 0.7 | GO:0046909 | intermembrane transport(GO:0046909) |
0.2 | 0.3 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.2 | 0.2 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.2 | 15.1 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.2 | 1.2 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 0.5 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.2 | 0.8 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.2 | 0.3 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.2 | 1.8 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.2 | 0.3 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.2 | 0.3 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.2 | 0.8 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.2 | 0.3 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.2 | 1.0 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.2 | 1.6 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.2 | 0.6 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.2 | 0.5 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.2 | 0.3 | GO:0061074 | regulation of neural retina development(GO:0061074) regulation of retina development in camera-type eye(GO:1902866) |
0.2 | 0.5 | GO:0060399 | regulation of growth hormone receptor signaling pathway(GO:0060398) positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.2 | 0.2 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.2 | 2.4 | GO:0003407 | neural retina development(GO:0003407) |
0.2 | 0.8 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.2 | 0.3 | GO:0009629 | response to gravity(GO:0009629) |
0.2 | 0.5 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.2 | 0.5 | GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) |
0.2 | 0.3 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.2 | 0.6 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.2 | 2.0 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.2 | 0.2 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.2 | 0.3 | GO:0090135 | actin filament branching(GO:0090135) |
0.2 | 0.2 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.2 | 0.3 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.2 | 0.6 | GO:0042637 | catagen(GO:0042637) |
0.2 | 0.3 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.2 | 0.9 | GO:0060180 | female mating behavior(GO:0060180) |
0.2 | 0.9 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.1 | 0.3 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 1.0 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.4 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.1 | 0.4 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 0.4 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.1 | 0.3 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 0.3 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.1 | 0.4 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.4 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 0.9 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.1 | 1.3 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.1 | 0.1 | GO:0061549 | sympathetic ganglion development(GO:0061549) |
0.1 | 0.6 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 0.3 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.3 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.1 | 0.7 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.1 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.1 | 0.4 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.1 | 0.4 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.1 | 1.3 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.1 | GO:0019230 | proprioception(GO:0019230) |
0.1 | 0.3 | GO:0060751 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
0.1 | 0.1 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.1 | 1.0 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) |
0.1 | 0.4 | GO:0015888 | thiamine transport(GO:0015888) |
0.1 | 0.7 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
0.1 | 0.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.4 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.1 | 0.3 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 0.3 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.1 | 0.4 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.1 | 0.4 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.1 | 0.1 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.1 | 2.4 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 0.9 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.1 | 0.4 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.1 | 0.1 | GO:0021544 | subpallium development(GO:0021544) |
0.1 | 0.4 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.3 | GO:0002086 | diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
0.1 | 0.3 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.1 | 0.8 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 1.4 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.1 | 0.1 | GO:1902837 | amino acid import into cell(GO:1902837) |
0.1 | 0.8 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.4 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.1 | 0.3 | GO:0006868 | glutamine transport(GO:0006868) |
0.1 | 0.1 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.1 | 0.3 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.9 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 0.3 | GO:1903147 | negative regulation of macromitophagy(GO:1901525) negative regulation of mitophagy(GO:1903147) |
0.1 | 0.4 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.1 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.1 | 2.2 | GO:0061245 | establishment or maintenance of apical/basal cell polarity(GO:0035088) establishment or maintenance of bipolar cell polarity(GO:0061245) |
0.1 | 0.1 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
0.1 | 0.6 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.1 | 0.2 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.1 | 0.4 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.1 | 1.2 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.1 | 0.1 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.1 | 0.2 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.1 | 0.5 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.1 | 3.1 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.1 | 0.1 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.1 | 0.1 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.1 | 0.4 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 1.3 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.1 | 0.3 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.1 | 0.3 | GO:0060463 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
0.1 | 0.2 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.1 | 0.1 | GO:1903170 | negative regulation of calcium ion transmembrane transport(GO:1903170) |
0.1 | 0.6 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.3 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.2 | GO:1902896 | terminal web assembly(GO:1902896) |
0.1 | 0.1 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.1 | 0.3 | GO:0050951 | sensory perception of temperature stimulus(GO:0050951) |
0.1 | 0.1 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) negative regulation of mesodermal cell fate specification(GO:0042662) |
0.1 | 0.1 | GO:0086011 | membrane repolarization during action potential(GO:0086011) regulation of membrane repolarization during action potential(GO:0098903) |
0.1 | 0.1 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.1 | 1.0 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.1 | 0.4 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.1 | 0.2 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.1 | 0.9 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.1 | 0.4 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 2.9 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.4 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.2 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.1 | 0.4 | GO:0048263 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.1 | 0.5 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
0.1 | 0.2 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.1 | 0.9 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.1 | 0.4 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 0.6 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 0.4 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.1 | 0.4 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.1 | 0.1 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.1 | 0.3 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.7 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.1 | GO:1901077 | regulation of relaxation of muscle(GO:1901077) |
0.1 | 0.1 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.1 | 0.8 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 0.9 | GO:0021766 | hippocampus development(GO:0021766) |
0.1 | 0.3 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.3 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
0.1 | 0.4 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.1 | 0.2 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.1 | 0.1 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.1 | 0.2 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.1 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
0.1 | 0.2 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.1 | 0.3 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.1 | 0.4 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.1 | 0.1 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.1 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.1 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.1 | 0.1 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.1 | 0.4 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.4 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.1 | 0.2 | GO:0030578 | PML body organization(GO:0030578) |
0.1 | 0.1 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.1 | 0.3 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 0.1 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.1 | 0.3 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.3 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.1 | 0.2 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.1 | 0.2 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.1 | 0.1 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.1 | 0.3 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 | 0.4 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.2 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.1 | 0.2 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.1 | 0.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.6 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 0.1 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
0.1 | 0.1 | GO:0070170 | regulation of tooth mineralization(GO:0070170) |
0.1 | 0.3 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.1 | 0.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.1 | GO:0010042 | response to manganese ion(GO:0010042) |
0.1 | 0.6 | GO:0014002 | astrocyte development(GO:0014002) |
0.1 | 1.0 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.1 | 0.6 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.1 | 0.2 | GO:0044851 | hair cycle phase(GO:0044851) |
0.1 | 0.1 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.1 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 1.1 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.1 | 0.5 | GO:0014741 | negative regulation of muscle hypertrophy(GO:0014741) |
0.1 | 0.1 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.1 | 0.1 | GO:0061046 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) regulation of branching involved in lung morphogenesis(GO:0061046) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.1 | 0.1 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.1 | 0.2 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.1 | 0.6 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.1 | 0.2 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 0.1 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.1 | 1.6 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.1 | 0.5 | GO:0036303 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.1 | 1.0 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.1 | 0.2 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.3 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.1 | 0.2 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 0.6 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.1 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 0.2 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.1 | 0.4 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.1 | 0.1 | GO:0002568 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.1 | 0.6 | GO:0043383 | negative T cell selection(GO:0043383) |
0.1 | 0.2 | GO:0034776 | response to histamine(GO:0034776) |
0.1 | 0.5 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 1.8 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.3 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.1 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.1 | 0.7 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.1 | 0.1 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.1 | 0.1 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.1 | 0.1 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.1 | 0.3 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.1 | 0.1 | GO:0032098 | regulation of appetite(GO:0032098) |
0.1 | 0.1 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.1 | 0.1 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.1 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.1 | 0.1 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.1 | 0.1 | GO:0032095 | regulation of response to food(GO:0032095) |
0.1 | 0.3 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.1 | 0.2 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.1 | 0.7 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.1 | 0.2 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.1 | 0.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 0.6 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.1 | 0.3 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.1 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.1 | 0.3 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 0.2 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 0.1 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.1 | 0.4 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 0.1 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.1 | GO:0010934 | macrophage cytokine production(GO:0010934) |
0.1 | 0.2 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.1 | 0.5 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.1 | 0.4 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.1 | 0.3 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.1 | 0.2 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.1 | 0.1 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.1 | 2.0 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.1 | 0.1 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.1 | 0.3 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.1 | 0.2 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 1.7 | GO:0050808 | synapse organization(GO:0050808) |
0.1 | 0.2 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.1 | 0.1 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.1 | GO:0007320 | insemination(GO:0007320) |
0.1 | 0.1 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.1 | 0.1 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.1 | 0.4 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.1 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.1 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.4 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.1 | 0.2 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 0.4 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.1 | 0.1 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.1 | 0.1 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.1 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.2 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.1 | 0.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.2 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.1 | 0.2 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 0.1 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.1 | 0.3 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.1 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.1 | 0.2 | GO:1904063 | negative regulation of cation transmembrane transport(GO:1904063) |
0.1 | 0.1 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.1 | 0.2 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.1 | 0.3 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.1 | 0.4 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.2 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
0.1 | 0.2 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.0 | 0.5 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.0 | GO:1904396 | regulation of synaptic growth at neuromuscular junction(GO:0008582) synaptic growth at neuromuscular junction(GO:0051124) regulation of neuromuscular junction development(GO:1904396) |
0.0 | 0.1 | GO:0043084 | penile erection(GO:0043084) |
0.0 | 0.1 | GO:0043380 | memory T cell differentiation(GO:0043379) regulation of memory T cell differentiation(GO:0043380) |
0.0 | 0.2 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.0 | 0.1 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) |
0.0 | 0.0 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.0 | 0.1 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.0 | 0.0 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.0 | 0.0 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.0 | 0.2 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.0 | 0.3 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.0 | 0.3 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.1 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.0 | 0.5 | GO:0043113 | receptor clustering(GO:0043113) |
0.0 | 0.4 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.0 | 0.1 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.0 | 0.3 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.4 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.6 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.2 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.0 | 0.3 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) |
0.0 | 0.0 | GO:0022038 | corpus callosum development(GO:0022038) |
0.0 | 0.1 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
0.0 | 0.2 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.5 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.0 | 0.4 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.1 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.0 | 0.6 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.0 | 0.0 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.0 | 0.0 | GO:0014047 | glutamate secretion(GO:0014047) |
0.0 | 0.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 0.0 | GO:0002371 | dendritic cell cytokine production(GO:0002371) regulation of dendritic cell cytokine production(GO:0002730) |
0.0 | 0.2 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 0.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.1 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.0 | 0.0 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.0 | 0.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.0 | 0.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.1 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.0 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.0 | 0.0 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.0 | 1.5 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.0 | 0.4 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.0 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.0 | 0.2 | GO:0032094 | response to food(GO:0032094) |
0.0 | 0.1 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.0 | 0.1 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.0 | 0.1 | GO:0003356 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
0.0 | 1.0 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.0 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.0 | 2.8 | GO:0006814 | sodium ion transport(GO:0006814) |
0.0 | 0.2 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.0 | 0.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.0 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.0 | 0.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.0 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.0 | 0.1 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.0 | 0.1 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
0.0 | 0.0 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.0 | 0.0 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.0 | 0.0 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.0 | 0.1 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.0 | 0.1 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.0 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.0 | 0.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 0.3 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
0.0 | 0.1 | GO:0098926 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.0 | 0.0 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.0 | 0.0 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.0 | 0.1 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.0 | 0.2 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.0 | 0.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.1 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.0 | 0.0 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.0 | 0.0 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.0 | 0.7 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.0 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.1 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.0 | 0.0 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.0 | 0.1 | GO:0070528 | protein kinase C signaling(GO:0070528) |
0.0 | 0.3 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 1.1 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.1 | GO:0007296 | vitellogenesis(GO:0007296) |
0.0 | 0.1 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.1 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.0 | 0.1 | GO:0032202 | telomere assembly(GO:0032202) |
0.0 | 0.1 | GO:0072567 | chemokine (C-X-C motif) ligand 2 production(GO:0072567) regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000341) |
0.0 | 0.3 | GO:0046068 | cGMP metabolic process(GO:0046068) |
0.0 | 0.9 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
0.0 | 0.0 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.0 | 0.2 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.0 | 0.1 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.0 | 0.1 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.0 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.0 | 0.0 | GO:0099612 | protein localization to paranode region of axon(GO:0002175) protein localization to axon(GO:0099612) |
0.0 | 0.0 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.0 | 0.0 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.0 | 0.0 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.0 | 0.1 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.0 | 0.0 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.0 | 0.0 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.0 | 0.0 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.0 | 0.0 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 0.1 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.0 | 0.1 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.0 | 0.0 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.0 | 0.0 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.0 | 0.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.0 | 0.0 | GO:0042048 | olfactory behavior(GO:0042048) |
0.0 | 0.2 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.0 | 0.0 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) |
0.0 | 0.0 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.0 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.1 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.0 | 0.2 | GO:0010165 | response to X-ray(GO:0010165) |
0.0 | 0.0 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.0 | 0.0 | GO:0060022 | hard palate development(GO:0060022) |
0.0 | 0.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.0 | 0.0 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.2 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.0 | 0.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.0 | 0.0 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.0 | 0.0 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
0.0 | 0.0 | GO:0060482 | lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
0.0 | 0.6 | GO:0007566 | embryo implantation(GO:0007566) |
0.0 | 0.0 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.0 | 0.1 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.0 | GO:0061337 | cardiac conduction(GO:0061337) |
0.0 | 0.0 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.0 | 0.0 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.0 | 0.0 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 0.0 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
0.0 | 0.0 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.0 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.0 | 0.0 | GO:0071675 | regulation of mononuclear cell migration(GO:0071675) |
0.0 | 0.0 | GO:0021799 | cerebral cortex radially oriented cell migration(GO:0021799) |
0.0 | 0.0 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.0 | 0.0 | GO:0007632 | visual behavior(GO:0007632) |
0.0 | 0.0 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.0 | 0.0 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.0 | 0.0 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.0 | 0.1 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 6.6 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
2.0 | 6.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.7 | 13.7 | GO:0043083 | synaptic cleft(GO:0043083) |
1.7 | 8.4 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
1.5 | 10.7 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.5 | 4.4 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
1.5 | 5.9 | GO:0044308 | axonal spine(GO:0044308) |
1.3 | 4.0 | GO:1990635 | proximal dendrite(GO:1990635) |
1.2 | 7.5 | GO:0005915 | zonula adherens(GO:0005915) |
1.2 | 13.1 | GO:0043194 | axon initial segment(GO:0043194) |
1.2 | 8.3 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
1.1 | 2.2 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
1.1 | 9.9 | GO:0005883 | neurofilament(GO:0005883) |
1.1 | 4.2 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.9 | 8.4 | GO:0030673 | axolemma(GO:0030673) |
0.9 | 21.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.9 | 7.2 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.9 | 6.8 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.8 | 5.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.8 | 31.6 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.8 | 25.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.8 | 2.3 | GO:0097441 | basilar dendrite(GO:0097441) |
0.8 | 5.3 | GO:0032584 | growth cone membrane(GO:0032584) |
0.7 | 5.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.7 | 3.7 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.7 | 7.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.7 | 2.1 | GO:0072534 | perineuronal net(GO:0072534) |
0.7 | 2.6 | GO:0030478 | actin cap(GO:0030478) |
0.6 | 9.7 | GO:0031527 | filopodium membrane(GO:0031527) |
0.6 | 0.6 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.6 | 14.8 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.6 | 1.8 | GO:0044393 | microspike(GO:0044393) |
0.6 | 3.5 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.5 | 5.8 | GO:0005916 | fascia adherens(GO:0005916) |
0.5 | 8.4 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.5 | 6.8 | GO:0031045 | dense core granule(GO:0031045) |
0.5 | 3.1 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.5 | 4.6 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.5 | 1.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.5 | 0.9 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.5 | 70.5 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.5 | 0.9 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.5 | 0.9 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.5 | 1.8 | GO:0042583 | chromaffin granule(GO:0042583) |
0.5 | 0.9 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.5 | 0.5 | GO:0031209 | SCAR complex(GO:0031209) |
0.4 | 13.1 | GO:0031941 | filamentous actin(GO:0031941) |
0.4 | 1.3 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.4 | 46.8 | GO:0060076 | excitatory synapse(GO:0060076) |
0.4 | 3.3 | GO:0034464 | BBSome(GO:0034464) |
0.4 | 3.8 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.4 | 1.6 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.4 | 3.4 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.4 | 6.4 | GO:0044295 | axonal growth cone(GO:0044295) |
0.3 | 6.0 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.3 | 1.3 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.3 | 3.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.3 | 1.7 | GO:0097433 | dense body(GO:0097433) |
0.3 | 0.3 | GO:0035838 | growing cell tip(GO:0035838) |
0.3 | 1.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.3 | 0.3 | GO:0097513 | myosin II filament(GO:0097513) |
0.3 | 0.3 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.3 | 0.6 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.3 | 2.6 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.3 | 1.2 | GO:0071437 | invadopodium(GO:0071437) |
0.3 | 2.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.3 | 0.9 | GO:0033269 | internode region of axon(GO:0033269) |
0.3 | 14.3 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.3 | 9.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.3 | 2.2 | GO:0032590 | dendrite membrane(GO:0032590) |
0.3 | 0.8 | GO:0048179 | activin receptor complex(GO:0048179) |
0.3 | 0.8 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.3 | 9.6 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.3 | 0.8 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 0.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 0.5 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 0.7 | GO:0043511 | inhibin complex(GO:0043511) |
0.2 | 2.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 0.9 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 0.6 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.2 | 3.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 1.9 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 2.5 | GO:0016580 | Sin3 complex(GO:0016580) |
0.2 | 1.2 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.2 | 2.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 0.7 | GO:0043203 | axon hillock(GO:0043203) |
0.2 | 2.1 | GO:0034704 | calcium channel complex(GO:0034704) |
0.2 | 1.1 | GO:0043198 | dendritic shaft(GO:0043198) |
0.2 | 0.5 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 0.2 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.2 | 1.3 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 3.2 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 0.3 | GO:1990357 | terminal web(GO:1990357) |
0.2 | 9.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.2 | 1.4 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.2 | 1.3 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 0.5 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.2 | 1.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 0.8 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 1.5 | GO:0005605 | basal lamina(GO:0005605) |
0.1 | 2.0 | GO:0071565 | nBAF complex(GO:0071565) |
0.1 | 3.4 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 0.5 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 0.3 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.1 | 1.0 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.5 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.1 | 0.4 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.1 | 0.4 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 1.0 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 17.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.6 | GO:0005818 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.1 | 0.2 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.1 | 0.5 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 30.6 | GO:0045202 | synapse(GO:0045202) |
0.1 | 0.2 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.1 | 0.6 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 0.1 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.1 | 2.0 | GO:0043679 | axon terminus(GO:0043679) |
0.1 | 1.0 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.7 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 0.4 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 0.5 | GO:0031430 | M band(GO:0031430) |
0.1 | 0.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 2.2 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.4 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 6.2 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 0.2 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 0.1 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 0.4 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.3 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 0.3 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 0.3 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.3 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 0.5 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 0.1 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.1 | 0.2 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.2 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.1 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 0.3 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.2 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 0.2 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 0.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.2 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.3 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.0 | 0.6 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 0.1 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.0 | 1.7 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.1 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.0 | 0.3 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.0 | 10.4 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.6 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.4 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.0 | 0.5 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.0 | 0.2 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 1.2 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.3 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 0.3 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 0.1 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.0 | 3.1 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.9 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.0 | 0.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.0 | 0.0 | GO:0031523 | Myb complex(GO:0031523) |
0.0 | 0.2 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 1.8 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.2 | GO:0030677 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.0 | 0.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.0 | 2.1 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.1 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 0.2 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 1.1 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.2 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.0 | 0.1 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 0.1 | GO:0044292 | dendrite terminus(GO:0044292) |
0.0 | 0.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.1 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.0 | 0.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.0 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.0 | 0.2 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 0.1 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.0 | 0.2 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.0 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.0 | 0.1 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.0 | 0.0 | GO:0000938 | GARP complex(GO:0000938) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 6.8 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
3.0 | 8.9 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
2.8 | 11.1 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
2.6 | 7.8 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
2.5 | 7.4 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
2.4 | 12.1 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.8 | 16.1 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
1.8 | 8.9 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
1.8 | 5.3 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
1.6 | 4.8 | GO:0070538 | oleic acid binding(GO:0070538) |
1.4 | 9.9 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
1.4 | 5.6 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.4 | 11.2 | GO:0002162 | dystroglycan binding(GO:0002162) |
1.4 | 9.7 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.3 | 2.6 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.3 | 7.7 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
1.2 | 9.7 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.2 | 8.3 | GO:0003680 | AT DNA binding(GO:0003680) |
1.1 | 4.4 | GO:0032051 | clathrin light chain binding(GO:0032051) |
1.1 | 8.7 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
1.1 | 5.4 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
1.1 | 3.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
1.1 | 3.2 | GO:0035939 | microsatellite binding(GO:0035939) |
1.1 | 5.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
1.0 | 3.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.0 | 4.0 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.9 | 2.8 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.9 | 4.3 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.8 | 1.7 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.8 | 4.2 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.8 | 5.0 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.8 | 3.3 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.8 | 9.0 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.8 | 2.4 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.8 | 5.5 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.8 | 19.0 | GO:0004120 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.8 | 3.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.8 | 2.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.7 | 2.2 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.7 | 3.7 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.7 | 1.5 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.7 | 15.9 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.7 | 7.9 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.7 | 9.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.7 | 1.4 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.7 | 2.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.7 | 2.9 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.7 | 2.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.7 | 1.3 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.6 | 2.6 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.6 | 12.8 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.6 | 3.8 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.6 | 1.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.6 | 7.4 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.6 | 2.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.6 | 4.8 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.6 | 1.2 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.6 | 2.9 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.6 | 1.7 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.6 | 6.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.6 | 2.2 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.5 | 0.5 | GO:0031013 | troponin I binding(GO:0031013) |
0.5 | 1.6 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.5 | 7.5 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.5 | 6.9 | GO:0031005 | filamin binding(GO:0031005) |
0.5 | 14.3 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.5 | 4.2 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.5 | 2.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.5 | 1.5 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.5 | 2.5 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.5 | 2.5 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.5 | 8.4 | GO:0004890 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
0.5 | 1.9 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.5 | 7.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.5 | 1.8 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.5 | 6.4 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.5 | 3.2 | GO:0043495 | protein anchor(GO:0043495) |
0.4 | 4.4 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.4 | 1.3 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.4 | 5.7 | GO:0005272 | sodium channel activity(GO:0005272) |
0.4 | 2.2 | GO:0048495 | Roundabout binding(GO:0048495) |
0.4 | 2.6 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.4 | 3.5 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.4 | 9.8 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.4 | 2.1 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.4 | 1.3 | GO:0070052 | collagen V binding(GO:0070052) |
0.4 | 11.8 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.4 | 10.0 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.4 | 0.4 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.4 | 3.3 | GO:0030552 | cAMP binding(GO:0030552) |
0.4 | 1.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.4 | 3.9 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.4 | 0.4 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.4 | 1.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.4 | 1.5 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.4 | 1.8 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.4 | 3.7 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.4 | 7.3 | GO:0003785 | actin monomer binding(GO:0003785) |
0.4 | 1.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.4 | 1.5 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.4 | 5.7 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.4 | 1.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.4 | 1.1 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.4 | 2.1 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.3 | 1.4 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) dopamine neurotransmitter receptor activity(GO:0004952) |
0.3 | 1.4 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.3 | 0.3 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.3 | 8.4 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.3 | 0.7 | GO:2001070 | starch binding(GO:2001070) |
0.3 | 1.0 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.3 | 3.4 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.3 | 0.7 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.3 | 6.0 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.3 | 0.3 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.3 | 1.0 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.3 | 7.9 | GO:0045296 | cadherin binding(GO:0045296) |
0.3 | 1.0 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.3 | 9.0 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.3 | 0.6 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.3 | 6.4 | GO:0042805 | actinin binding(GO:0042805) |
0.3 | 3.5 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.3 | 0.9 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.3 | 1.2 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.3 | 5.1 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.3 | 2.4 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.3 | 0.3 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.3 | 1.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.3 | 1.1 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 0.6 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.3 | 1.1 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.3 | 0.8 | GO:0034956 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.3 | 0.8 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.3 | 1.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.3 | 6.6 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.3 | 5.0 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.3 | 17.5 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.3 | 0.8 | GO:0018589 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.3 | 7.4 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.3 | 5.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.3 | 0.8 | GO:0071253 | connexin binding(GO:0071253) |
0.3 | 1.5 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.3 | 5.8 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 0.7 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.2 | 3.2 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.2 | 0.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.2 | 2.1 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 4.3 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 1.2 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.2 | 0.7 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.2 | 0.9 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.2 | 0.7 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.2 | 2.1 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.2 | 0.9 | GO:0034584 | piRNA binding(GO:0034584) |
0.2 | 3.9 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.2 | 0.2 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.2 | 1.6 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 0.7 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.2 | 0.9 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.2 | 0.9 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.2 | 1.3 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.2 | 0.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.2 | 1.9 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 1.0 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.2 | 1.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 2.0 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 1.2 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.2 | 0.4 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 0.2 | GO:0051378 | serotonin binding(GO:0051378) |
0.2 | 0.6 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.2 | 2.1 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 0.4 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.2 | 0.9 | GO:0017040 | ceramidase activity(GO:0017040) |
0.2 | 1.8 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 0.9 | GO:0036122 | BMP binding(GO:0036122) |
0.2 | 0.6 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.2 | 0.5 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.2 | 1.6 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 0.5 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.2 | 0.4 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.2 | 0.5 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.2 | 0.5 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.2 | 0.5 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.2 | 1.6 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.2 | 0.2 | GO:0038191 | neuropilin binding(GO:0038191) |
0.2 | 0.9 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 0.3 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.2 | 0.9 | GO:0038132 | neuregulin binding(GO:0038132) |
0.2 | 0.2 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.2 | 1.7 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.2 | 1.7 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 0.3 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.2 | 9.4 | GO:0044325 | ion channel binding(GO:0044325) |
0.2 | 2.0 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.2 | 1.0 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 1.3 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 2.6 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 0.5 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.2 | 0.2 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.2 | 1.6 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.2 | 0.5 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.2 | 4.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.2 | 0.5 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.2 | 0.9 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.1 | 0.6 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.1 | 0.3 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 0.4 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 0.1 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.1 | 9.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.9 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.7 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.7 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.1 | 0.7 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.1 | 0.4 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 1.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.7 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 1.0 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.4 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.7 | GO:0034838 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.1 | 0.3 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 1.7 | GO:0022841 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.1 | 0.8 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 1.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 0.4 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 2.8 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 1.0 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.1 | 0.3 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.1 | 0.6 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 1.4 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 1.3 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 1.4 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 1.0 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.5 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.1 | 0.2 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 0.5 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 0.7 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.1 | 0.7 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 0.7 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.5 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.1 | 0.7 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.1 | 0.7 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 0.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 1.7 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 1.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.3 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.1 | 0.1 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 1.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 9.4 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 2.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.4 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.4 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.2 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 0.8 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 0.9 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 1.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 1.9 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 1.2 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.5 | GO:0031402 | sodium ion binding(GO:0031402) |
0.1 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.4 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.1 | 0.3 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 1.6 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.4 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.5 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.1 | 9.5 | GO:0005516 | calmodulin binding(GO:0005516) |
0.1 | 1.2 | GO:0016248 | channel inhibitor activity(GO:0016248) |
0.1 | 0.7 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 0.3 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.1 | 1.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.4 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.1 | 0.3 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.5 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.3 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.4 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 3.2 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.1 | 0.3 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.1 | 0.3 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 2.0 | GO:0005262 | calcium channel activity(GO:0005262) |
0.1 | 0.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 0.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.1 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.1 | 0.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.1 | GO:0030519 | snoRNP binding(GO:0030519) |
0.1 | 0.2 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.1 | 1.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.3 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.1 | 0.8 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 0.2 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.6 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.1 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.1 | 1.1 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 1.6 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.5 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.1 | 0.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 1.6 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 0.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 0.3 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.3 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.1 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.1 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.1 | 0.7 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 0.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.4 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.5 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.2 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 0.2 | GO:0005267 | potassium channel activity(GO:0005267) |
0.1 | 0.6 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.2 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.2 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 0.2 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.1 | 0.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 0.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 0.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.1 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.1 | 0.1 | GO:0048030 | disaccharide binding(GO:0048030) |
0.0 | 0.6 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 1.8 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.1 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 1.0 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 1.0 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.6 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.0 | 0.4 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.7 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.2 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 0.4 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.0 | 0.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.0 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.0 | 0.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.0 | 1.5 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.2 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.0 | 0.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.3 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 0.2 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.1 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.0 | 0.2 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.0 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.3 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.3 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.0 | 0.1 | GO:0002134 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.0 | 0.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.4 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.1 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 0.2 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.0 | 0.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.0 | 17.3 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.5 | GO:0030594 | neurotransmitter receptor activity(GO:0030594) |
0.0 | 0.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.2 | GO:0034802 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) phenanthrene 9,10-monooxygenase activity(GO:0018636) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.0 | 0.0 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 0.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.1 | GO:1901567 | icosanoid binding(GO:0050542) icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.0 | 0.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.1 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.6 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 0.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 0.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.1 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.0 | 0.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.0 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.0 | 0.2 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.1 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.0 | 0.1 | GO:0035671 | enone reductase activity(GO:0035671) |
0.0 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.1 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.0 | 0.1 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.1 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.1 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.0 | 0.1 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.6 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.1 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 4.7 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.4 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.1 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.0 | 1.0 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.2 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.2 | GO:0052736 | dextrin alpha-glucosidase activity(GO:0044653) starch alpha-glucosidase activity(GO:0044654) beta-glucanase activity(GO:0052736) beta-6-sulfate-N-acetylglucosaminidase activity(GO:0052769) glucan endo-1,4-beta-glucosidase activity(GO:0052859) |
0.0 | 0.2 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.0 | 6.6 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.1 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 0.1 | GO:0016247 | channel regulator activity(GO:0016247) |
0.0 | 0.4 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 0.0 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.0 | 0.0 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.0 | 0.2 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.3 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.0 | 0.0 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.0 | GO:0030957 | Tat protein binding(GO:0030957) |
0.0 | 0.1 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.0 | 0.0 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.0 | 0.1 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.0 | 0.0 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 0.0 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.0 | 0.1 | GO:0008517 | folic acid transporter activity(GO:0008517) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 11.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.7 | 3.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.5 | 12.0 | PID REELIN PATHWAY | Reelin signaling pathway |
0.5 | 14.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.4 | 4.0 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.4 | 13.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.4 | 9.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.4 | 5.2 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.4 | 9.4 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.4 | 3.9 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.3 | 5.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.3 | 4.0 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.3 | 4.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.3 | 4.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.3 | 10.5 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.3 | 0.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.3 | 3.9 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 2.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 2.4 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 0.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.2 | 3.6 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.2 | 7.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 3.9 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 2.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 1.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 0.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 7.7 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.2 | 2.6 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 1.7 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.2 | 4.2 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 0.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 2.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 1.9 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 2.8 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 1.8 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 2.8 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 2.8 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.9 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 0.1 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 2.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 1.6 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 1.5 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 1.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 1.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 1.6 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 0.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 0.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 0.4 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 0.1 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 0.8 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 1.0 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 0.6 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 0.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 7.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.8 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 2.2 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.2 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.0 | 0.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 6.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 1.2 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.5 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.2 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.6 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.8 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.0 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 3.8 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.4 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 20.9 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.2 | 10.8 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
1.0 | 14.0 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.0 | 22.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.9 | 18.0 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.9 | 18.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.8 | 6.7 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.8 | 17.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.7 | 0.7 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.7 | 4.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.6 | 7.1 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.6 | 9.0 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.6 | 3.8 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.6 | 10.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.6 | 1.8 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.5 | 7.1 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.5 | 10.9 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.4 | 17.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.4 | 4.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.4 | 5.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.4 | 7.2 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.4 | 4.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.4 | 8.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.4 | 13.5 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.3 | 3.8 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.3 | 4.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.3 | 1.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.3 | 6.4 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.3 | 5.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.3 | 0.9 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.3 | 4.4 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.2 | 1.0 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.2 | 1.9 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.2 | 0.7 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.2 | 0.5 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.2 | 1.2 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.2 | 4.1 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.2 | 0.2 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.2 | 3.6 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.2 | 5.1 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.2 | 1.7 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 2.4 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 1.9 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.2 | 2.2 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 5.2 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.2 | 1.2 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 3.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 1.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 2.7 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.2 | 2.0 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.2 | 1.7 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.2 | 25.9 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.2 | 2.7 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 1.2 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.2 | 1.7 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 0.4 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.1 | 0.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 5.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 1.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 2.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 2.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.3 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.1 | 0.1 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.1 | 0.9 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 0.1 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.1 | 1.4 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 2.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 1.4 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 0.1 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 1.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 4.5 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.2 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 0.2 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 0.1 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 1.0 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 1.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.9 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 0.7 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.1 | 5.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 1.1 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 0.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 1.4 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 0.6 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 0.7 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.1 | 0.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 0.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 0.1 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.1 | 1.2 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.0 | 0.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 1.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.0 | REACTOME CELL CELL COMMUNICATION | Genes involved in Cell-Cell communication |
0.0 | 0.9 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.0 | 0.2 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.0 | 1.4 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.0 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.5 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.3 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.2 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.1 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.2 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.1 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.0 | 0.2 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.0 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 0.0 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |